Cross comparison of our DEGs to a E2F1 cistrome revealed many E2F1 target genes (E2f7, Rtel1, Myc, Ybx3 and Id3) being downregulated in β1 integrin-deficient tumours, consistent with slow tumour growth phenotype (Fig. 4f). The gene discussed is MYC; the disease is neoplasm.